Video - Results from #120

Bladder Cancer VL

Helping Patients Cope after Major Interventions for Bladder Cancer Therapy Details Stephen Williams and Ashish Kamat discuss the paper, Impact of Psychiatric Illness on Decreased Survival in Elderly Patients with Bladder Cancer in the United States, a study which addresses problems that bladder cancer patients face and the difficulties they experience coping after major interventions for bladder cancer therapy. The conversation also includes recommendations on how to educate and...
The Changing Landscape in Advanced Bladder Cancer - Tom Keane Details (Length of Discussion: 16 min) Dr. Tom Keane discusses the rapidly changing landscape in advanced bladder cancer with the introduction of immune checkpoint inhibitors. To begin his discussion he references a presentation by Thomas Powles, MD from the 2018 ASCO GU meeting where Dr. Powles provided an overview of immune checkpoint inhibitors in urothelial carcinoma at the current time and Dr. Powles...
Advances in Bladder Cancer - Systemic Therapies Including Immunotherapy - Petros Grivas Details (Length of Discussion: 30 min) Petros Grivas and Alicia Morgans discuss the progress in systemic and immunotherapy in advanced bladder cancer. They discuss the biologic and immunologic background of urothelial cancer that paves the way for the development of potential biomarkers, as well as possible therapeutic targets in this disease. They share insights on the significant advances in systemic th...
Minimizing Treatment Burden and Biomarkers in Bladder Cancer - Badrinath Konety Details Badrinath Konety and Alicia Morgans discuss biomarkers in bladder cancer. Concepts highlighted include incorporating clinical and other disease characteristics into biomarkers, so outcomes can be more accurately predicted. Biographies: Badrinath Konety, MD, MBA , is professor and chair at the University of Minnesota, where he holds the Dougherty Family Chair in Uro-Oncology and is Director of the...
A Revolutionizing Time in Immuno-Oncology for Bladder Cancer - Neal Shore Details (Length of Discussion: 20 min) There has been a limited number of new therapeutics, particularly in the area of patients who would benefit from advanced systemic bladder cancer treatments. Dr. Neal Shore reviews some pioneering work from the past such as MVAC and gemcitabine platinum based combinations but he notes those treatments are where things were left for many many years. The development of...
Enhanced Recovery After Surgery (ERAS) for Radical Cystectomy: History, Rationale and Programmatic Implementation - Thomas Guzzo Details (Length of Discussion: 34 min) Dr. Thomas Guzzo starts his discussion by dialing back to 1997 to share with listeners the beginning of Enhanced Recovery After Surgery (ERAS) and the work of Dr. Kelhlet from Denmark who described multifactorial surgical stress responses such as the pathogenesis of postoperative sleep disturbances as multifactorial, and includes different neural stimulus (surgical s...
Treatment Options for Bladder Cancer: Bringing Life to Years of Sparse Options - Guru Sonpavde Details (Length of Discussion - 9 min) Dr. Alicia Morgans discusses with Dr. Guru Sonpavde the advances in the field of bladder cancer in regards to immunotherapy treatment approaches and recent ongoing clinical trials. Dr. Morgans refers to these treatment options and new studies as bringing a freshness to a desert like climate which has been bladder cancer treatment over the past several decades. Dr. So...
Enhanced Recovery After Surgery (ERAS) Radical Cystectomy and Urinary Diversion- Ashish Kamat Details Ashish Kamat, MD presents: Enhanced Recovery After Surgery (ERAS) Radical Cystectomy and Urinary Diversion. This video lectures discusses the background, framework, importance of GI recovery and improvements of quality of life with ERAS. Dr. Kamat also emphasizes the importance of recognizing different readmission factors and appropriate follow up procedures. For reference, PDF version of slides B...

Bladder Cancer VL

Login